Cryo-Save Group N.V. (Euronext: CRYO, `Cryo-Save`, or `the Group`), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that, further to its 13 May 2014 announcement that it shall change its name to Esperite, it has convened an extra-ordinary general meeting of shareholders (`EGM`) to be held on 2 July 2014, which is to implement this change and to resolve on the change of the Company`s name to Esperite N.V.
The EGM`s convocation notice, agenda and the explanatory notes to the agenda are available free of charge at the Company`s offices in Zutphen, the Netherlands and can be downloaded from the Company`s website, www.cryo-save.com/group.
|Cryo-Save Group||+ 31 (0) 575 548 998|
|Frederic Amar, CEO|
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, stores more than 250,000 samples from umbilical cord blood and cord tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Cryo-Save has cryopreserved samples from over 70 countries on six continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, and South Africa.
Press Release in PDF
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cryo-Save Group N.V. via GlobeNewswire